Michael Reed Ph.D. — Chief Science Officer and Senior Vice President of Research & Development at OraSure Technologies

Dr. Michael Reed, also known as Mike, Ph.D. has been Chief Science Officer and Senior Vice President of Research & Development at OraSure Technologies, Inc. since April 18, 2016. Dr. Reed joined OraSure after having spent the last eight years as part of the management team at Beckman Coulter, a global diagnostics and life sciences company within the Danaher Corporation. At Beckman Coulter, Dr. Reed served in a variety of leadership positions including Director of Global Assay and Applications Development for the Beckman Coulter Life Science business encompassing flow cytometry, genomics and capillary electrophoresis reagent development and Director of Scientific Affairs for the Cellular Analysis Business Group, including flow cytometry and hematology reagent research and development and clinical affairs. Prior to Beckman Coulter, Dr. Reed served as Director of Product Development at Osmetech Molecular Diagnostics where he led the effort to develop two U.S.FDA 510K cleared IVD systems for cystic fibrosis genotyping and a pharmacogenetics test to guide warfarin dosing. He also worked at the predecessor company ?????? Clinical Micro Sensors. He has more than 20 years of experience in life sciences and diagnostics research and development across an extensive array of disciplines including globally regulated IVD development and commercialization of molecular and cellular applications and systems. He conducted post-doctoral research at the Beckman Research Institute at the City of Hope in Duarte, California. Dr. Reed received a Ph.D. degree in Biochemistry from the University of Adelaide (Australia) and a BSc. in Biochemistry from The Australian National University (Canberra, Australia).